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Membrane lipidsApoptosis is an active and tightly regulated form of cell death, which can also be considered a stress-induced
process of cellular communication. Recent studies reveal that the lipid network within cells is involved in
the regulation and propagation of death signalling. Despite the vast growth of our current knowledge on
apoptosis, little is known of the speciﬁc role played by lipid molecules in the central event of apoptosis—the
piercing of mitochondrial membranes. Here we review the information regarding changes in mitochondrial
lipids that are associated with apoptosis and discuss whether they may be involved in the permeabilization of
mitochondria to release their apoptogenic factors, or just lie downstream of this permeabilization leading to
the ampliﬁcation of caspase activation. We focus on the earliest changes that physiological apoptosis induces
in mitochondrial membranes, which may derive from an upstream alteration of phospholipid metabolism
that reverberates on the mitochondrial re-modelling of their characteristic lipid, cardiolipin. Hopefully, this
review will lead to an increased understanding of the role of mitochondrial lipids in apoptosis and also help
revealing new stress sensing mechanisms in cells. This article is part of a Special Issue entitled Mitochondria:
the deadly organelle.ondria: the deadly organelle.
+44 161 275 5600.
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It is now established that mitochondria play a central role in all
major pathways of cell death. The best characterized programs of cell
death are autophagy and apoptosis, with its two intersecting major
pathways of death receptor-mediated and mitochondria-mediated
signalling. There is an intriguing inter-dependence of death programs,
so that cells in which apoptosis is impaired often die by autophagy,
and vice-versa [1]. The major link that connects both programs seems
to be the mitochondrion and, in particular, its membranes [1,2]. The
purpose of this article is to provide an updated overview of how the
lipid components of mitochondrial membranes become involved in
apoptosis and may contribute to the regulation and propagation of
death signalling. Besides the complex protein network that con-
tributes to death signalling, there is also the network formed by the
metabolic and trafﬁc connections of membrane lipids.While the study
of the protein network is advanced, the understanding of the role of
the lipid network is limited, even if its importance is evident. Indeed,
both apoptosis and autophagy require speciﬁc lipids in upstream
reactions of their pathways and subsequent processes that ultimately
characterize cell destruction. For instance, macroscopic changes of
cellular lipids sustain the sequence of blebbing and formation of
apoptotic bodies in cells dying by apoptosis, whereas proliferationof intracellular lipids drives the formation of autophagosomal
membranes in autophagy—as well as other form of death not
requiring caspases [1,3]. Mitochondria play a central role in the
network of cellular lipids, especially at the level of their outer
membrane (OM), which is a crucial crossover in lipid metabolism.
Here the key steps of lipid degradation and fatty acid synthesis occur,
together with reactions that are essential for the biosynthesis of
phosphatidyl-ethanolamine (PE), of ceramide-based lipids and also of
mature cardiolipin (CL). Notably, CL is the onlymembrane component
that is synthesized by mitochondria, but in immature forms that are
then rapidly re-modelled by reactions pivoting on the OM [3,4].
Herein, we will focus on the changes of mitochondrial lipids–
especially phospholipids–that occur during apoptosis, which could
affect the physico-chemical properties of the OM and the pro-
apoptotic action of Bcl-2 proteins that speciﬁcally interact with this
membrane, leading to its permeabilization (mitochondrial outer
membrane permeabilization, MOMP). We will discuss selected new
points regarding CL, since previous reviews have amply covered
various aspects of its involvement in cell death [3–5]. To sustain these
points, we will present unpublished data from our ongoing research,
illustrating how little we still know about the involvement of
mitochondrial lipids in cell death.
2. Changes in mitochondrial membrane lipids during apoptosis
Several membranes actively participate in the process of cell death
through changes in their lipid composition and potentially also after
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have a role in apoptosis is phosphatidylserine (PS), which is now
established to act as a “eatme” signal formacrophages once exposed at
the surface of apoptotic cells [7]. Externalization of PS is predomi-
nantly driven by activated caspases and therefore is frequently used
as an apoptotic marker of caspase-dependent death. However,
transient PS exposure can occur independently of caspase activation,
for instance in cell motility [8] and platelet activation [9]. Although
cellular PS is predominantly synthesized in the mitochondria-
associated membranes of the endoplasmic reticulum (ER), there
seems to be no evidence of signiﬁcant changes in mitochondrial PS
during apoptosis, except for situations of oxidative stress.
Oxidative stress is one of the most used triggers of apoptosis
because it bears relevance to a number of pathological conditions,
for instance neurodegeneration [1]. Conditions of oxidative stress
invariably increase the peroxidation of mitochondrial lipids [10,11]. In
addition, apoptosis induced by diverse stimuli is frequently accom-
panied by the generation of peroxidized lipids, generally grouped
within reactive oxygen species (ROS). Some of these peroxidized
phospholipids, especially the truncated forms of phosphatidylcholine
(PC), directly induce apoptosis in certain cellular contexts [12].
Preferential oxidation of PS has been shown to occur after apoptosis
induction with pro-oxidants, including organic hydroperoxides,
paraquat, and azo-initiators of peroxyl radicals (for a review, see
[11]). A likely reason for this preferential peroxidation of PS, which is
frequently correlated to its externalization during apoptosis [13], is its
high content of poly-unsaturated fatty acids [14,15]. Here we will not
further discuss oxidative changes of mitochondrial lipids, which are
amply reviewed by Kagan and co-workers [11], also because they
occur downstream MOMP and the activation of executioner caspases
during death receptor-mediated apoptosis [3,16–19]. Ceramide is
another lipid that has been extensively studied for its implications inTable 1
Changes in mitochondrial lipids during apoptosis. In italics are those changes that appear t
Lipid species Cell system Death stimulus
Linoleyl-PCa Mouse liver Fas ligation
Oleyl-PCa Jurkat T Fas ligation
LPC Mouse liver Fas ligation
LPC Jurkat T Fas ligation
LPC Jurkat T TRAIL
DAG Mouse liver Fas ligation
DAG Jurkat T Fas ligation
DAG U937 Fas ligation
MCL Mouse liver Fas ligation
MCL Jurkat T Fas ligation
MCL Jurkat T TRAIL
MCL U937 Fas ligation
Cardiolipins Mouse liver Fas ligation
Cardiolipins Jurkat T Fas ligation
Cardiolipins Jurkat T TRAIL
Cardiolipins U937 Fas ligation
Cardiolipins Cardiomyocytes palmitate
Cardiolipins Granulosa stearate
Cardiolipin Neurones PC starvation
LPC Jurkat T Erucyl-PC
Oleyl-PC+ Jurkat T Erucyl-PC
Cardiolipins Jurkat T Erucyl-PC
Phosporylated PI Jurkat T Erucyl-PC
Truncated ox PC Mouse liver Truncated ox PC
Phosporylated PI Mouse liver Fas ligation
Phosporylated PI U937 Fas ligation
Acyl-PG/SLBPA Mouse liver Fas ligation
Acyl-PG/SLBPA Jurkat T Fas ligation
Acyl-PG/SLBPA U937 Fas ligation
Peroxidized CL Various cells Pro-oxidants
Peroxidized PS A549 cells Fas ligation
GD3 Jurkat, U937 Fas ligation
a While in most mammalian tissues linoleyl (C18:2) is the predominant acyl species of CL,
the same proﬁle.
b M. Degli Esposti, unpublished.signalling and apoptosis [20,21]. Cellular ceramide levels increase in
response to a variety of apoptotic stimuli (e.g. TNFα, Fas ligand, IFNγ,
UV irradiation and DNA damage) and have been reported to produce
alterations in bioenergetics, ROS generation and also permeabilization
of the mitochondrial OM [20,21]. However, the latter effect is unclear
since activation of sphingomyelinases, the upstream event responsi-
ble for the transient accumulation of ceramide during apoptosis,
has been shown to be caspase-dependent [22]. In contrast with the
reports of others [20,21], our studies have indeed failed to detect
a signiﬁcant increase in the levels of major ceramide species in
mitochondria before the activation of executioner caspases [23,24].
Conversely GD3, a ceramide-based glycolipid, has been reported to
accumulate in mitochondria (Table 1, see also [25]).
Although ceramide and its related glycolipids have been reported
to be involved in apoptosis [20–22,25], these lipids are only minor
components of mitochondrial membranes that remain conﬁned to the
OM, together with lipids typical of the ER/plasmamembrane such as
cholesterol [26]. The major components of mitochondrial membranes
are phospholipids and numerous results document changes in their
content or chemistry during death receptor-mediated apoptosis—the
most physiological model of cell death. We have summarized these
changes in Table 1, also in relation to the timing of the MOMP for
outlining their possible involvement in this central event of apoptosis
signalling. Some lipid changes associated with death receptor-
mediated apoptosis occur also with intrinsic stimuli, in particular
treatment with exogenous lipids (Table 1). For instance palmitate, a
saturated (16:0) fatty acid found in plasma at high concentrations
during ischemia and reperfusion, has been observed to induce
apoptosis in many biological systems, including cardiomyocytes and
breast cancer cells [27,28]. At the level of mitochondria, treatment
with palmitate decreases the complement of CL, primarily due to a
diminished concentration of fatty acid precursors needed for optimalo occur before or concomitantly with the onset of MOMP.
CHANGE Timing vs. MOMP Reference
decrease Before b
decrease Before [24], b
increase Before and after [24]
increase Before and after [3,24]
increase Before and after [23]
increase Before and After [3]
increase Before [24], b
increase Before [19]
increase Before and after [3,30]
increase Before and after [30]
increase Before and after [23]
increase Before and after [19]
decrease Before and after [3,30]
decrease Before and after [30,100]
decrease Before and after [23]
decrease Before and after [19]
decrease Not tested [29]
decrease Not tested [29]
decrease Not tested [10]
increase Before b
decrease Before b
decrease Before and after b
increase Before and after b
increase Before and after [12]
increase Before and after [3]
increase Before and after [19], b
increase After [19], b
increase After [30], b
increase Before and after [19]
increase Before and after [11]
increase After [18]
increase After? [25]
in haematopoietic cells like Jurkat oleyl (C18:1) is more common [4]; PC species reﬂect
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treatment of human granulosa cells with another saturated fatty acid,
stearate (C18:0) [29].
The summary presented in Table 1 indicates that only a few of the
lipid changes associatedwith apoptosis appear to occur beforeMOMP. It
is important to elaborate on these changes, because they could be
instrumental in the process of MOMP itself, by “priming” for the pro-
apoptotic action of Bcl-2 proteins [3,30,31]. Within the model of death
receptor apoptosis, the most prominent early change is the increase in
two common lysolipids, C16:0 and C18:1 lysophosphatidyl-choline
(LPC) [3,24]. The majority of this LPC is likely to originate outside
mitochondria and then accumulate in the OM. Even if detailed studies
on the lipid composition of the OM are missing, this possibility is
supported by robust data showing an early increase in LPC–with a
parallel decrease ofmajor PC species suchasC16:0,C18:2 PC (linoleyl PC,
Table 1)–in light membrane fractions comprising ER and endosomes.
These changes occur within 30 min of Fas stimulation in both liver and
haematopoietic cells and seem to derive from an early inhibition of
phosphocholine cytidylyltransferase (CCT), the rate-limiting enzyme in
PC biosynthesis [32]. Indeed, inhibition of CCT with alkyl-lysoPC
derivatives such as erucyl-PC [33] reproduces, in exacerbated form,
the same changes observed in intracellular membranes during Fas-
mediated apoptosis (Table 1). Since diacyl-glycerol (DAG) is a substrate
of CCT, its early accumulation in mitochondria (Table 1) is consistent
with upstream inhibition of CCT activity in the ER [32]. The absence
of phospholipase activation in mitochondria [3] further supports the
extra-mitochondrial origin of the LPC species that accumulate in the
mitochondrial membranes of apoptotic cells.
The other change that appears to occur beforeMOMP is an increase
in the ﬁrst metabolite of CL, monolysocardiolipin (MCL), often
concomitantly with the initial loss of CL (Table 1 cf. [30]). Given
that degradation of CL to MCL is normally catalyzed by lysosomal
phospholipases, which are unlikely to be released from lysosomes
before MOMP [34], the increase in MCL could be connected to that of
LPC and the parallel decrease of parent CL and PC species by enhanced
re-modelling of cardiolipin [3,4]. This process, which occurs predom-
inantly in the OM [4], could well be stimulated by the upstream deﬁcit
in PC biosynthesis mentioned above, because PC is the fundamental
donor of the unsaturated acyl groups that are required to re-model
nascent CL into its mature, dominant forms present in cells [4,35]. The
scenario that thus emerges is that death receptor activation may ﬁrst
induce a block in PC biosynthesis at the level of the plasmamembrane
and its parts internalized within the endosomal and ER compart-
ments, which then reverberates on the OM by dynamic transport of
lipid species [36], as well as inter-mixing with the membranes of
other organelles [6]. The latter possibility is supported by the early
accumulation of protein markers of endosomes and the intermediate
compartment ERGIC in mitochondria [3,6,37,38]. On the other hand,
the transport of LPC to mitochondria could be catalyzed by Bid, a pro-
apoptotic Bcl-2 protein which has intrinsic capacity of transferring
this and other lipids between ER and mitochondrial membranes
[24,36,39,40]. Strong evidence has been recently reported for the lipid
transfer activity of Bid using truncated oxidized PC compounds, which
structurally resemble LPC and accumulate in a Bid-dependent manner
within mitochondria [12].
In summary, we are beginning to understand the early changes in
mitochondrial lipids that occur before, or concomitantly with MOMP.
They relate to upstream alterations in lipid metabolism that
reverberate onto mitochondria via membrane trafﬁc routes and the
lipid transfer action of Bid, which indeed accumulates inmitochondria
of apoptotic cells (reviewed in [3]). Thus, changes in lipid metabolism
together with protein- and vesicles-mediated lipid transport can also
act as a stress-sensing mechanism. Subsequent changes in mitochon-
drial lipids (Table 1) may amplify the damage to the organelle, or
simply reﬂect downstream processes that spontaneously follow the
early changes, but cannot substantially contribute to the MOMP.3. Lipid changes vs. membrane structure (curvature and lipid pores)
As we have seen, apoptosis induces speciﬁc changes in the lipid
composition of the plasma membrane and various intracellular
membranes. However, the most critical changes during apoptosis
occur in mitochondria, where they favour the permeabilization of
the OM to release apoptogenic factors into the cytoplasm. While
membrane-associated proteins induce and regulate structural
changes in intracellular membranes, lipids play a fundamental role
in facilitating these changes within the membrane architecture. The
chemical properties of different lipid acyl chains or headgroups can
favour different membrane curvatures: for example, lysophosphatidic
acid (LPA) and phosphatidic acid (PA), which are converted by
LPA:acyl transferase and phospholipase A2 activity, respectively,
favour opposite curvatures [41–43]. Non-lamellar lipids with a large
effective hydrophilic part relative to the effective hydrophobic part,
exempliﬁed by LPC, possess positive intrinsic curvature, whereas
non-lamellar lipids with a small effective hydrophilic part relative
to their hydrophobic part, such as unsaturated species of PE and
DAG, possess negative intrinsic curvature [44,45]. Notably, both LPC
and DAG increase early in mitochondria after stimulation of death
receptors (Table 1). Interaction of Bax with lipid vesicles is partially
modulated by changes in membrane curvature due to different
combinations of the above lipids [31,44–46]. It is also known that
mitochondrial lipids will convert from a lamellar to a hexagonal
phase in the presence of Ca+2 [47]. However, on balance the effect of
membrane curvature seems to be less important than other aspects
of membrane lipids for generating MOMP in vivo [48].
How do lipids contribute to MOMP then? The best models are
bacterial toxins that permeate lipid membranes, given the structural
similarity of Bcl-2 proteins with some of these toxins [50]. Although
ceramide has been shown to form channels in the OM [21], pure
lipid pores are rare in nature. Conversely, various bacterial toxins
recruit speciﬁc lipids to form proteolipid aggregates that produce
discontinuities in the lipid bi-layer (reviewed in [3,51]). Whenever
these discontinuities are maintained for a time longer than that
taken by the later mobility of the lipids to ﬁll the gap, the permeability
barrier is lost and diverse molecules can cross the membrane in
both directions. In analogy with bacterial toxins, conformational
changes and oligomerization of pro-apoptotic Bid [52,53] and Bax [54]
could provide the driving force to produce discontinuities leading to
membrane permeabilization—namely “proteolipid pores” [31,49].
These structural changes have been documented to occur with
detergents (reviewed in the article of Lindsay et al in this BBA issue)
and membrane lipids [40,45,52,55–62]. By considering the early
changes observed in mitochondrial membranes (Table 1), CL, DAG
and lysolipids are the membrane lipids most likely to be involved
in the piercing of the OM by activated Bcl-2 proteins. As we will
now see, these lipids are interconnected by metabolic pathways of
CL re-modelling.While CL has been extensively studied, little is known
of the potential roles of lysolipids in MOMP. We will thus review
existing information on lysolipids in cell death, before discussing
recent literature on CL.
4. Lysolipids and cell death
Lysolipids not only are essential metabolites of membrane lipids,
but also natural detergents. Ceramides have detergent-like properties
too [21]. As detergents, these natural lipids can disrupt the integrity
of the lipid bi-layer and participate to dynamic changes in the
organization of intracellular membrane organelles, including mito-
chondria. Concentrations of lysolipids, or ceramides, above their
critical micellar concentration can be cytotoxic, as they break the
plasmamembrane like detergents [63]. This effect would apply also to
various cell-free assays that use isolated mitochondria and prepara-
tions of recombinant tBid that are kept in solution with non-ionic
Fig. 1. Bid binds to a ﬂuorescent analogue of CL in competition with LPC. Recombinant
mouse Bid [40] was conjugated to AlexaFluor350, a blue ﬂuorescent dye, and then
puriﬁed by size-exclusion chromatography. Spectra were obtained in PBS with
excitation at 346 nm, before (black solid line) and after (red line) equilibration with
50 nM of MCL-BODIPY, a green ﬂuorescent derivative of cardiolipin [93]. Note the clear
increase in BODIPY ﬂuorescence at around 520 nm, which indicates energy transfer
from binding to the Bid conjugate (FRET) (cf. [59]). The subsequent addition of 5 μM
LPC (16:0, dotted line) removes this increase in green ﬂuorescence, but not the
corresponding quenching in blue ﬂuorescence around 440 nm, indicating that binding
competition between CL and micellar LPC could be incomplete, or involves some
conformational changes.
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[12] and alkyl-lysoPC derivatives [33] can be cytotoxic even at sub-
micellar concentrations, or in the presence of medium albumin
that normally sequesters most of the lipid in solution. They are
incorporated by endocytosis in the trafﬁc of cellular membranes and
can interfere with the activity of lipid degrading enzymes [68,69],
or the structure and function of mitochondrial membranes [12].
Conversely, natural LPC can be beneﬁcial to cells in culture, which
rely in precursors obtained from the growth medium for the essential
de novo biosynthesis of PC [10,32,69,70]. Exogenous LPC, once
incorporated within cellular membrane, becomes immediately acyl-
ated by acyl-transferase enzymes using endogenous lipids as donors,
thereby producing new PC molecules by scavenging other phospho-
lipids, or triglycerides [32]. Indeed, exogenous LPC can correct the PC
deﬁciency produced by CCT inhibition [69]. The same PC deﬁciency,
when not supported by exogenous biosynthetic sources, leads to
rapid accumulation of LPC within cells, as in the case of Fas-mediated
apoptosis mentioned earlier (Table 1). Another way of increasing LPC
is by the enhanced activity of phospholipases that generally occurs
downstream of caspase activation [71–73]. Some of the LPC produced
in this way is then secreted outside cells, providing an important long
distance signal to attract phagocytes towards apoptotic cells [72,73].
The alternative mechanism explaining the increased levels of
LPC (and other lysolipids, cf. Table 1) in mitochondria would be an
enhanced re-modelling of CL, which primarily requires PC species
as acyl donors [4,74]. It is now established that this remodelling
fundamentally follows a transacylation reaction, which uses PC
species resident in the OM or arriving from the ER to re-acylate MCL
formed by hydrolysis of the immature CL species that are produced in
the inner mitochondrial membranes [4]. LPC is the product of the
transacylation of MCL to CL and is normally removed from the
reaction by re-acylation by acyl-CoA-dependent acyl-transferases [4].
However, upstream deﬁciency in PC production and subsequent
accumulation of extra-mitochondrial LPC in the OM will inevitably
shift the equilibrium of the transacylation towards the formation of
MCL and PC. The pattern of changes observed in mitochondria of Fas-
stimulated cells seems to match the expected alteration in this
transacylation reaction of CL re-modelling, because LPC increases in
parallel with both an initial decrease in CL and an increase in MCL
(Table 1). The consequence of a reverse transacylation of CL to LPC
would also be a diverse spectrum of PC species in mitochondria, a
situation that is found in several models of apoptosis (Table 1 and M.
Degli Esposti, unpublished data). An additional increase in MCL
species may derive from its limited re-acylation by other routes,
e.g. those present in the ER [3]. Furthermore, the increased levels of
DAG may stimulate the biosynthesis of phosphatidyl-glycerol (PG)
and its acyl-derivatives, which indeed accumulate in mitochondria of
apoptotic cells (Table 1, cf. [19]).
Intriguingly, Bid binds to both LPC and CL as well as MCL, thereby
providing a link between metabolic alterations in PC biosynthesis
and CL re-modelling in the OM [30]. This link has also a catalytic
dimension because Bid is capable of transporting LPC between
different membranes [24,36,39]. The Bid-mediated insertion of LPC
into membranes produces transient perturbation of the lipid bi-layer
[24], similarly to the effect of activated Bax [45,46,48,75]. However,
this perturbation is generally insufﬁcient to produce enough mem-
brane de-stabilization to abrogate the permeability barrier of
liposomes or mitochondria. Something else has to be present in
the membrane to allow Bid to bind ﬁrmly and then facilitate
the interaction of Bax or Bak with the lipid bi-layer leading to the
disruption of its continuity. CL and/or MCL can constitute this
essential component because: a) Bid binds to these lipids, also in
exchange with LPC (as shown in Fig. 1, cf. [24,40]); b) binding to
mitochondrial CL/MCL induces stable oligomerization of Bid [30]. LPC
and certain detergents such as SDS also induce some oligomerization
of Bid, but only at micellar concentrations [40,52]), similarly toBax [54,76] and Bcl-xL [77]. In contrast, CL and MCL produce stable,
discrete oligomers of Bid that match those found after adding the
protein to mitochondria or their lipid extracts (M. Degli Esposti,
unpublished data, cf. Ref. [30]). Of note, other lysolipids do not induce
the same oligomerization of Bid, indicating biochemical speciﬁcity
like a lipid-interacting enzyme [24,30,36,40].
5. Cardiolipin in apoptosis—an update
Cardiolipin (CL) is a unique glycerol-based phospholipid, which is
composed of four acyl groups and two phosphate moieties. Unlike
other phospholipids, the acyl groups of mammalian CL are essentially
restricted to C18:2 chains (linoleic acid) that are required for optimal
function of many enzyme complexes involved in oxidative phosphor-
ylation [36,78]. CL is considered to be a speciﬁc component of
mitochondria, since it is synthesized within the inner mitochondrial
membrane. However, it can exit mitochondria and reach the
plasmamembrane in some models of apoptosis [19], thereby
suggesting that its intracellular location is dynamic and not conﬁned
within the organelle of its origin [3]. Even if CL is present almost
exclusively within the inner mitochondrial membrane, it is also found
in the OM (approximately 4% of the lipid content of mammals) and
even more at the contact sites connecting the OM with the inner
membrane [79]. Recent ﬁndings have suggested two additional
routes by which CL can reach the OM from the inner mitochondrial
membrane: (1) via the catalytic activity of phospholipid scramblase 3
[80]; (2) via transient associationwith oligomeric kinases in the inter-
membrane space [81]. How the inter-membrane transfer of CL is
integratedwith its re-modelling remains unclear, given that themajor
re-modelling enzyme, tafazzin, seems to be predominantly located in
the inner membrane [4]. Several independent studies suggest that
CL has either survival- or death-supporting roles in cells (for recent
reviews on various aspects of cardiolipin, see [4,5]). In addition to
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involvement in apoptosis.
It is basically established that CL does play a role in the concerted
pro-apoptotic action of Bcl-2 family proteins. Regarding model
systems with artiﬁcial liposomes, recent prominent studies have
clariﬁed that there is no effective release of trapped indicators [59], or
permeation of externally added indicators [67] without CL in the
liposomal membranes. In biological systems including mitochondria,
of particular note is the recent work of Martinou's group showing that
selective degradation of mitochondrial CL impairs the pro-apoptotic
action of tBid plus Bax [60]. All these recent reports support earlier
works indicating a role of CL in the modulation of the pro-apoptotic
action of Bid and other Bcl-2 proteins [3,82].
Besides CL, some membrane proteins have been implicated in the
mitochondrial association of tBid and Bax [49,83] (reviewed in the
article of Lindsay et al in this BBA issue). The cumulative evidence thus
points to a combination of lipid-protein mixtures, i.e. microdomains
containing CL, in the expression and regulation of the pro-apoptotic
action of Bcl-2 proteins. Several aspects of putative mitochondrial
microdomains have been reviewed recently [5,25]. Here we mention
them in connection with the involvement of Bcl-2 proteins in the
dynamic changes of mitochondrial morphology due to fusion and
ﬁssion of their membranes [84–88]. Of note, CL accumulates at the cell
poles of bacteria before their division [89–92], contributing to the
structural changes associated with the process of cell membrane
ﬁssion [89,92]. Because mitochondria divide by a ﬁssion mechanism
that is comparable to that of their bacterial ancestors, microdomains
enriched in CL may accumulate at the membrane poles in the
elongation process, contributing to the coordinated ﬁssion of their
inner and outer membranes [84]. This process involves membrane
tubulation, a stretching of the bi-layer in which CL clusters seem to
participate, probably because they can provide transient stabilization
of the elongated membrane structures that then lead to organelle
ﬁssion [88]. Similar membrane alterations have been reported in
liposomes supplemented with tBid and Bax [49].
Intriguingly, we have recently observed a striking accumulation
of a ﬂuorescent CL analogue in long membrane protrusions which
connect T cells, called membranes nanotubes (Fig. 2, cf. [93]). It is thus
possible that the clustering of activated Bax and Bak in foci of
mitochondrial ﬁssion (for a review, see [84,94]) reﬂects an underlying
accumulation of CL-enriched microdomains in the OM, which in turn
may drive the oligomerization and pro-apoptotic action of the sameFig. 2. Accumulation of exogenous CL in membrane nanotubes. Jurkat T cells were
attached to coverslip after incubationwith lipid vesicles containing the same ﬂuorescent
analogue of CL as that used in Fig. 1, thenﬁxed and imaged by deconvolutionmicroscopy
[93]. The small arrow indicates vesicles that have not yet been internalized within
the cell, while the large arrow indicates amembrane nanotube connecting two cells that
appears enriched in MCL-BODIPY staining.proteins. Bid or tBidmay facilitate the assembly of thesemicrodomains
by aggregating together with speciﬁc CL and MCL molecules, as
observed with different experimental approaches [30,40,52,55].
Although the caspase-cleaved form of Bid, tBid, is predominantly
used in model systems for studying MOMP [52,55,59,67,82,83], it is
worth noting that also the full length protein binds to CL (Fig. 1) and
displays pro-apoptotic capacity withmitochondria [19,39,47]. It is just
less catalytically efﬁcient than tBid, which has a higher afﬁnity for CL
and MCL than the full length protein [30]. Although tBid has a much
larger hydrophobic surface than the full-length protein, the tight
packing of the N-terminal region cleaved by caspases would cover
most of it [64,95]. Yet, caspase-cleaved Bid (namely “cut” Bid, even if
often it is called tBid) acquires the propensity of self-aggregation even
in the absence of lipids or detergents [30]. Thus caspase-cleaved
Bid is actually a suspension of protein aggregates under the usual
conditions of the in vitro assays, a property that may be instrumental
for accelerating its pro-apoptotic activity. Even in this self-aggregated
state, tBid retains the capacity of binding tightly to CL and its
metabolites [30], as well as interacting with other Bcl-2 proteins and
lipid membranes [53,59]. However, it loses the capacity of forming
oligomers with LPC and detergents [30,39]. This seems to be a
biophysical property that clearly distinguishes caspase-cleaved Bid
from its parent protein and could represent a biological switch to
irreversibly associate it to mitochondria during apoptosis [96].
6. Conclusions and perspectives
In this review we hope to have clariﬁed the following issues:
(1) After apoptosis induction, the initial lipid changes that are
observed in mitochondria appear to reﬂect an upstream
deﬁciency in the biosynthesis of PC impacting on the re-
modelling of CL;
(2) lysolipids are prominent among these initial changes and may
play a crucial, yet largely unexplored role in facilitating the pro-
apoptotic action of Bax and Bak and the onset of MOMP;
(3) Bid provides a link between upstream PC deﬁciency and
mitochondrial membranes by transporting LPC to the OM; thus,
probably it contributes to disequilibrium in the transacylation
of CL re-modelling;
(4) binding to CL or MCL produce stable oligomers of (t)Bid that ﬁx
the protein onto the membrane surface, thereby providing the
attractor for Bax and Bak action on the same membrane;
(5) peroxidation of CL and other lipid changes observed in
mitochondria (Table 1) essentially occur after MOMP; hence,
they may only amplify the release of cytochrome c and conse-
quent caspase cascade.
In perspective, it can be considered that speciﬁc lipid metabolites
and the binding of these molecules by proteins controlling apoptotic
signalling may form a new stress sensing mechanism that act prior
to the involvement of mitochondrial membranes. Lipid molecules,
and in particular lysolipids, may thus have unexplored signalling roles
in sensing death stimuli and other developmental cues within cells.
In the plant kingdom, lysolipids have already been reported to be
directly involved in signalling pathways of mycorrhizal and rhizobial
symbiosis [97,98]. Perhaps new signalling routes involving lysolipids
are about to be discovered in animals too, following the precedent of
LPA [99].
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